Project Grant HT94252510359
Award Date 8/15/25
Completion Date 8/14/27
Dollars Obligated $300K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Similar Awards
- This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development federal grant program (CFDA 12.420), provides $705,038 to Yale University for the "Development of GUAR-T as a Novel Class of Universal Cellular Immunotherapies for Ovarian Cancer." The project aims to conduct advanced biomedical research to transform healthcare for military service members, veterans, and the general public by developing innovative immunotherapies for ovarian...
- The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $2,098,194 project grant to Tilt Biotherapeutics OY to research novel cancer immunotherapies. The three-year project, titled "UNLEASHING THE FULL POTENTIAL OF CHECKPOINT INHIBITOR ANTIBODIES WITH T-CELL-STIMULATING ONCOLYTIC ADENOVIRUSES FOR TREATMENT OF OVARIAN CANCER", aims to develop a combination therapy using checkpoint inhibitor antibodies and oncolytic adenoviruses to...
- The U.S. Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), has awarded a $954,000 project grant to the Massachusetts Institute of Technology (MIT) for the research project "TUMOR-TARGETED NANOCARRIERS FOR EFFECTIVE IMMUNOMODULATION OF OVARIAN CANCER". The grant, with a performance period from May 1, 2025 to April 30, 2028, will support advanced biomedical research aimed at developing innovative medical solutions for military personnel...
- This Project Grant award titled "OVARIAN CANCER ACADEMY: ADVANCING OVARIAN CANCER RESEARCH THROUGH MENTORSHIP, NETWORKING, AND COLLABORATIONS" is funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The $1,305,270 award to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, will support advanced biomedical research to transform healthcare for military...
- This $405,000 Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports Panorama Research Incorporated's development of a novel antibody-based immunotherapy to enhance ovarian tumor responses to treatment. The project aims to create a switchable split superantigen fused with antibodies targeting binary tumor-specific receptors, with the goal of boosting the effectiveness of immunotherapy for ovarian cancer patients. As a...
- The Defense Health Agency awarded Dana-Farber Cancer Institute a $1,046,135 project grant under the Military Medical Research and Development program to conduct research titled "Drugging the Undruggable: Programming Ovarian Cancer Cells as the Next-Generation Immunotherapy." The three-year award runs from May 15, 2023 to May 14, 2026. As the prime recipient, Dana-Farber will leverage its expertise in tumor biology, immunology and drug development to research new therapies for ovarian...
- The Defense Health Agency awarded a $1,290,499.00 Project Grant to the Dana-Farber Cancer Institute, Inc. (DFCI) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "ENHANCING THE ANTITUMOR ACTIVITY OF NATURAL KILLER CELLS IN OVARIAN CANCER," is focused on conducting research to develop innovative approaches to understanding, detecting, and treating ovarian cancer. DFCI, a prestigious non-profit cancer research center, will...
- This Project Grant award for $699,750 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to the University of Washington aims to support the discovery and characterization of tissue-specific regulatory mutations that predispose to ovarian cancer. The award will fund research activities over a 3-year period from April 2024 to March 2027. As a leading research university, the University of Washington has extensive experience managing federal grants and...
- The Department of the Army Medical Command awarded a $990,000 project grant to the Provincial Health Services Authority in Canada to support research on mechanisms and therapeutic strategies for overcoming MNA-mediated immune suppression in ovarian cancer. The grant was awarded under the Military Medical Research and Development program (CFDA 12.420), which aims to transform health care for service members and the public through innovative biomedical research solutions for battlefield...
- The University of Oklahoma Health Sciences Center (OUHSC) was awarded a $427,109 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research titled "Targeting DCLK1-Mediated Glutamine Addiction in Chemoresistant Ovarian Cancer Metastases". The research project aims to transform healthcare for military service members and the public by investigating innovative medical solutions for addressing ovarian cancer,...